Search - tctmd.com

Displaying 801 - 820 of 1545

Sort: Relevancy | Date

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

L.A. McKeown

September 20, 2013

News Industry News

Corindus Vascular Robotics Launches Extensive Study of Robotic Angioplasty Effectiveness and Safety

September 16, 2013

News Daily News

Increase in Radial PCI at VA Hospitals Imparts Lower Transfusion Rates

September 13, 2013

News Daily News

El Aumento de PCI Radiales en Hospitales de Veteranos acarrea Índices Más Bajos de Transfusiones

September 13, 2013

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times

September 03, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

News Conference News ESC 2013

TASTE: No Appetite for Manual Thrombus Aspiration

September 01, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

Post-PCI Bleeding Risk Higher in Women, Linked with Mortality

August 30, 2013

News Daily News

Los Riesgos Hemorrágicos Post-PCI son Más Altos en Mujeres que en Hombres y se asocian a la Mortalidad

August 30, 2013

News Daily News

FAME 2: La PCI Guiada por FFR resulta ‘Atractiva Económicamente’ comparada con Solo el Tratamiento Médico

Caitlin E. Cox

August 30, 2013

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

El Uso de Terapia Antianginosa Previa a una PCI en el Tratamiento de la EAC Estable Parece Bajo e Inconsistente

L.A. McKeown

August 23, 2013

News Daily News

Antianginal Therapy Use Before PCI in Stable CAD Appears Low, Inconsistent

L.A. McKeown

August 23, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

Advertisement

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

Corindus Vascular Robotics Launches Extensive Study of Robotic Angioplasty Effectiveness and Safety

Increase in Radial PCI at VA Hospitals Imparts Lower Transfusion Rates

El Aumento de PCI Radiales en Hospitales de Veteranos acarrea Índices Más Bajos de Transfusiones

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

TASTE: No Appetite for Manual Thrombus Aspiration

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Post-PCI Bleeding Risk Higher in Women, Linked with Mortality

Los Riesgos Hemorrágicos Post-PCI son Más Altos en Mujeres que en Hombres y se asocian a la Mortalidad

FAME 2: La PCI Guiada por FFR resulta ‘Atractiva Económicamente’ comparada con Solo el Tratamiento Médico

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

El Uso de Terapia Antianginosa Previa a una PCI en el Tratamiento de la EAC Estable Parece Bajo e Inconsistente

Antianginal Therapy Use Before PCI in Stable CAD Appears Low, Inconsistent

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content